CN110236197A - 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 - Google Patents
海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN110236197A CN110236197A CN201910402999.5A CN201910402999A CN110236197A CN 110236197 A CN110236197 A CN 110236197A CN 201910402999 A CN201910402999 A CN 201910402999A CN 110236197 A CN110236197 A CN 110236197A
- Authority
- CN
- China
- Prior art keywords
- parts
- sea cucumber
- oil
- cucumber intestine
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 60
- 210000000936 intestine Anatomy 0.000 title claims abstract description 49
- 239000007901 soft capsule Substances 0.000 title claims abstract description 23
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 22
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 22
- 210000004681 ovum Anatomy 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000004347 Perilla Nutrition 0.000 claims abstract description 13
- 241000195493 Cryptophyta Species 0.000 claims abstract description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 10
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims abstract description 10
- 229960000304 folic acid Drugs 0.000 claims abstract description 10
- 235000019152 folic acid Nutrition 0.000 claims abstract description 10
- 239000011724 folic acid Substances 0.000 claims abstract description 10
- 229940067606 lecithin Drugs 0.000 claims abstract description 10
- 235000010445 lecithin Nutrition 0.000 claims abstract description 10
- 239000000787 lecithin Substances 0.000 claims abstract description 10
- 229940050168 zinc lactate Drugs 0.000 claims abstract description 10
- 235000000193 zinc lactate Nutrition 0.000 claims abstract description 10
- 239000011576 zinc lactate Substances 0.000 claims abstract description 10
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 9
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 9
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 9
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 9
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 8
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 235000019198 oils Nutrition 0.000 claims description 66
- 239000002775 capsule Substances 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 9
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004513 sizing Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 230000036760 body temperature Effects 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 229940060184 oil ingredients Drugs 0.000 claims 17
- 239000002075 main ingredient Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 6
- 208000007536 Thrombosis Diseases 0.000 abstract description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 49
- 239000000047 product Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000021081 unsaturated fats Nutrition 0.000 description 2
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930188089 Holothurin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- MAWWITJOQDJRJF-ADBICINLSA-M holothurin Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@]7(O)[C@](C)([C@H]8OC(C)(C)CC8)OC(=O)[C@@]76[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](C)[C@H]1O MAWWITJOQDJRJF-ADBICINLSA-M 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明提出一种海参肠卵油组合物、海参肠卵油软胶囊及其制备方法，属于生物技术领域，所得海参肠卵油软胶囊成分丰富、效果明显，可有效用于预防脂肪含量升高引起的动脉血管硬化、血栓等疾病。该技术方案海参肠卵油组合物，按重量份计，包括海参肠卵油10‑20份、藻油8‑12份、紫苏子油3‑5份、牛磺酸0.4‑0.6份、叶酸0.4‑0.6份、葡萄糖酸锌3‑5份、乳酸锌0.1‑0.3份、维生素E 5‑10份、卵磷脂1‑3份和大豆磷脂10‑20份。本发明能够应用于海参肠卵的深度开发利用中。
Description
技术领域
本发明属于生物技术领域，尤其涉及一种海参肠卵油组合物、海参肠卵油软胶囊及其制备方法。
背景技术
传统的海参油往往从海参中提取，提取海参油之后的海参难以二次加工使用。与此同时，海参肠卵在加工过程中一般被丢弃或者作为花肥，带来了严重的浪费。
随着研究的深入，以前在海参加工中被丢弃或被用于饲料使用的原本属于海参加工副产品的肠卵(内脏和性腺，也叫海参花)，经研究发现也含有丰富的海参的各种营养物质，如含有较丰富的海参皂甙(海参素或海参活素)及多种海参多肽及多种氨基酸、还含有丰富的不饱和脂肪酸成分，如磷脂、神经节苷脂、脑苷脂及其他的不饱和脂肪酸等。进而，海参肠卵的功效也不断被发现并得到医学上的重视，海参肠卵的这些成分具有提高机体免疫力、抑制肿瘤、抗凝血、保护神经组织的生理功能。
目前，随着生活水平的不断提高，人们对高脂肪肉类食品的摄入量不断增加，伴随而来的是血液中脂肪含量的不断升高，由此引起的动脉血管硬化、血栓等疾病日益影响和危害了中老年人的健康和生活质量。为了预防此类疾病的发生，人们开始食用一些海参油类产品，但是市场上现有的海参油类产品较少、成分简单、功能单一、效果不明显。
发明内容
本发明提出一种海参肠卵油组合物、海参肠卵油软胶囊及其制备方法，所得海参肠卵油软胶囊成分丰富、效果明显，可有效用于预防脂肪含量升高引起的动脉血管硬化、血栓等疾病。
为了达到上述目的，本发明提供了一种海参肠卵油组合物，按重量份计，包括海参肠卵油10-20份、藻油8-12份、紫苏子油3-5份、牛磺酸0.4-0.6份、叶酸0.4-0.6份、葡萄糖酸锌3-5份、乳酸锌0.1-0.3份、维生素E 5-10份、卵磷脂1-3份和大豆磷脂10-20份。
作为优选，按重量份计，包括海参肠卵油20份、藻油10份、紫苏子油5份、牛磺酸0.5份、叶酸0.5份、葡萄糖酸锌5份、乳酸锌0.2份、维生素E 7份、卵磷脂3份和大豆磷脂15份。
本发明还提供了一种保健品/美容保健品，以上述技术方案所述的海参肠卵油组合物为主要成分。
作为优选，所述保健品为口服制剂。
本发明还提供了一种海参肠卵油软胶囊，以上述技术方案所述的海参肠卵油组合物为主要成分。
本发明还提供了一种根据上述技术方案所述的海参肠卵油软胶囊的制备方法,包括以下步骤：
内容物的配制：按重量份分别称取金枪鱼油、鳕鱼油、藻油、紫苏子油、松籽油、牛磺酸、叶酸、葡萄糖酸锌、乳酸锌、卵磷脂和大豆磷脂；
将上述原料利用胶体磨均质后，制得外观均匀的混悬液，将混悬液搅拌60-80min，制得均一稳定的内容物，备用；
囊材的配制：按质量比8:10:3分别称取囊材原料明胶、甘油和纯水，先将甘油和纯水混合搅拌并加热至60℃，然后加入明胶，搅拌20-30min后，进行真空脱泡，制得囊材，备用；
灌装：将调配的内容物放入盛装料斗中，根据内容物的装量，选择滚模、调节压丸参数，制成软胶囊，其中，每粒软胶囊中的内容物重0.50g；
制粒：将制成的软胶囊经压丸、定型、筛滤、洗丸、烘丸、拣丸和分装，制成海参肠卵油软胶囊。
作为优选，压丸参数具体为：胶囊壳压制温度：52℃，喷体温度：42℃，胶囊壳厚度：0.8mm，滚模转速：1.8rpm/min。
与现有技术相比，本发明的优点和积极效果在于：
本发明提供了一种海参肠卵油组合物以及由该海参肠卵油组合物制备得到的海参肠卵油软胶囊，该海参肠卵油软胶囊由内容物和囊材两部分组成，通过调配、灌装、制粒等步骤制备得到。该工艺合理、可操作性强，易于工业化生产；所得海参肠卵油软胶囊成分丰富、效果明显，可有效用于预防脂肪含量升高引起的动脉血管硬化、血栓等疾病。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
海参肠卵油组合物，按重量份计，包括海参肠卵油10份、藻油8份、紫苏子油3份、牛磺酸0.5份、叶酸0.4份、葡萄糖酸锌3份、乳酸锌0.1份、维生素E 5份、卵磷脂2份和大豆磷脂10份。
实施例2
海参肠卵油组合物，按重量份计，包括海参肠卵油15份、藻油12份、紫苏子油5份、牛磺酸0.5份、叶酸0.6份、葡萄糖酸锌5份、乳酸锌0.3份、维生素E 10份、卵磷脂1份和大豆磷脂20份。
实施例3
海参肠卵油组合物，按重量份计，包括海参肠卵油20份、藻油10份、紫苏子油5份、牛磺酸0.5份、叶酸0.5份、葡萄糖酸锌5份、乳酸锌0.2份、维生素E 7份、卵磷脂3份和大豆磷脂15份。
实施例4
将实施例1中的原料利用胶体磨均质后，制得外观均匀的混悬液，将混悬液搅拌60-80min，制得均一稳定的内容物，备用；
按质量比8:10:3分别称取囊材原料明胶、甘油和纯水，先将甘油和纯水混合搅拌并加热至60℃，然后加入明胶，搅拌20-30min后，进行真空脱泡，制得囊材，备用；
将保温的胶料桶与胶囊机连接，将调配的内容物放入胶料桶的料斗中，根据内容物装量，选择滚模，调节压丸参数，压丸参数具体为：胶囊壳压制温度：52℃，喷体温度：42℃，胶囊壳厚度：0.8mm，滚模转速：1.8rpm/min，制成软胶囊，其中，每粒软胶囊中的内容物重0.50g；
将制成的软胶囊经压丸、定型、筛滤、洗丸、烘丸、拣丸和分装，制成海参肠卵油软胶囊。
实施例5
与实施例4步骤相同，区别在于所加入的原料为实施例2中所列举重量份的原料。
实施例6
与实施例4步骤相同，区别在于所加入的原料为实施例3中所列举重量份的原料。
本发明实施例4-6制备方法所制备得到的海参肠卵油软胶囊由内容物和囊材两部分组成，并通过调配、灌装、制粒等步骤制备得到。内容物中以海参肠卵由为主、搭配藻油以及紫苏子油，配以其他辅助组分，其中，藻油是一种纯植物性DHA，属于Omega-3不饱和脂肪酸家族中的重要成员，其从人工培育的海洋微藻中提取，对胎婴儿智力和视力发育至关重要；紫苏子油是以紫苏籽为原料提取的食用油，含а-亚麻酸达56.14-64.82％,а-亚麻酸是人体必需的脂肪酸，它在人体中转化为代谢必要的生命活性因子DHA和EPA，不含胆固醇，对人体具有更显著的保健功能和医药功效。三者搭配使用，既解决了目前市场上海参油类产品较少、成分简单、功能单一的缺陷，又可有效用于预防脂肪含量升高引起的动脉血管硬化、血栓等疾病，效果明显。
Claims (7)
1.海参肠卵油组合物，其特征在于，按重量份计，包括海参肠卵油10-20份、藻油8-12份、紫苏子油3-5份、牛磺酸0.4-0.6份、叶酸0.4-0.6份、葡萄糖酸锌3-5份、乳酸锌0.1-0.3份、维生素E5-10份、卵磷脂1-3份和大豆磷脂10-20份。
2.根据权利要求1所述的海参肠卵油组合物，其特征在于，按重量份计，包括海参肠卵油20份、藻油10份、紫苏子油5份、牛磺酸0.5份、叶酸0.5份、葡萄糖酸锌5份、乳酸锌0.2份、维生素E7份、卵磷脂3份和大豆磷脂15份。
3.保健品/美容保健品，其特征在于，以权利要求1或2所述的海参肠卵油组合物为主要成分。
4.根据权利要求3所述的保健品/美容保健品，其特征在于，所述保健品为口服制剂。
5.海参肠卵油软胶囊，其特征在于，以权利要求1或2所述的海参肠卵油组合物为主要成分。
6.根据权利要求5所述的海参肠卵油软胶囊的制备方法,其特征在于，包括以下步骤：
内容物的配制：按重量份分别称取金枪鱼油、鳕鱼油、藻油、紫苏子油、松籽油、牛磺酸、叶酸、葡萄糖酸锌、乳酸锌、卵磷脂和大豆磷脂；
将上述原料利用胶体磨均质后，制得外观均匀的混悬液，将混悬液搅拌60-80min，制得均一稳定的内容物，备用；
囊材的配制：按质量比8:10:3分别称取囊材原料明胶、甘油和纯水，先将甘油和纯水混合搅拌并加热至60℃，然后加入明胶，搅拌20-30min后，进行真空脱泡，制得囊材，备用；
灌装：将调配的内容物放入盛装料斗中，根据内容物的装量，选择滚模、调节压丸参数，制成软胶囊，其中，每粒软胶囊中的内容物重0.50g；
制粒：将制成的软胶囊经压丸、定型、筛滤、洗丸、烘丸、拣丸和分装，制成海参肠卵油软胶囊。
7.根据权利要求6所述的制备方法,其特征在于，压丸参数具体为：胶囊壳压制温度：52℃，喷体温度：42℃，胶囊壳厚度：0.8mm，滚模转速：1.8rpm/min。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910402999.5A CN110236197A (zh) | 2019-05-15 | 2019-05-15 | 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910402999.5A CN110236197A (zh) | 2019-05-15 | 2019-05-15 | 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110236197A true CN110236197A (zh) | 2019-09-17 |
Family
ID=67884039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910402999.5A Pending CN110236197A (zh) | 2019-05-15 | 2019-05-15 | 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110236197A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114794480A (zh) * | 2021-01-29 | 2022-07-29 | 大连鑫玉龙海洋生物种业科技股份有限公司 | 一种海参肠卵油-dha胶囊及其制作方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991113A (zh) * | 2010-11-30 | 2011-03-30 | 青岛佳日隆海洋食品有限公司 | 一种海参油软胶囊及其制备方法 |
| CN102488718A (zh) * | 2011-12-27 | 2012-06-13 | 深圳市麦金利实业有限公司 | 一种鱼油软胶囊及其制备方法 |
| CN103637243A (zh) * | 2013-11-22 | 2014-03-19 | 威海博宇食品有限公司 | 一种海参软胶囊及其制备方法 |
| CN107699359A (zh) * | 2017-11-24 | 2018-02-16 | 黑龙江美丽石岛科技开发有限公司 | 一种海参肠卵油的提取工艺及利用海参肠卵油制备海参肠卵油软胶囊的方法 |
-
2019
- 2019-05-15 CN CN201910402999.5A patent/CN110236197A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991113A (zh) * | 2010-11-30 | 2011-03-30 | 青岛佳日隆海洋食品有限公司 | 一种海参油软胶囊及其制备方法 |
| CN102488718A (zh) * | 2011-12-27 | 2012-06-13 | 深圳市麦金利实业有限公司 | 一种鱼油软胶囊及其制备方法 |
| CN103637243A (zh) * | 2013-11-22 | 2014-03-19 | 威海博宇食品有限公司 | 一种海参软胶囊及其制备方法 |
| CN107699359A (zh) * | 2017-11-24 | 2018-02-16 | 黑龙江美丽石岛科技开发有限公司 | 一种海参肠卵油的提取工艺及利用海参肠卵油制备海参肠卵油软胶囊的方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114794480A (zh) * | 2021-01-29 | 2022-07-29 | 大连鑫玉龙海洋生物种业科技股份有限公司 | 一种海参肠卵油-dha胶囊及其制作方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105613789A (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
| CN104522649B (zh) | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 | |
| CN103960657A (zh) | 一种能调节人体新陈代谢、分解体内脂肪的火龙果酵素制剂及制备方法 | |
| CN107125736A (zh) | 一种覆盆子酵素的制备方法 | |
| CN102318827B (zh) | 一种促进神经系统发育的营养素组合物及保健品 | |
| CN107136511A (zh) | 一种促进脑神经发育的牡丹籽油组合物、牡丹籽油软胶囊及其制备方法 | |
| CN104605440A (zh) | 一种椰汁饮料及其制备方法 | |
| CN108835262A (zh) | 一种改善记忆力的调制乳粉及其制备方法 | |
| CN112167165A (zh) | 一种复配过瘤胃多不饱和脂肪酸粉的制备及其应用 | |
| CN101449751A (zh) | 一种富含多不饱和脂肪酸的蛋鸡用饲料 | |
| CN101878798A (zh) | 一种黑米骨泥高钙营养饼干 | |
| CN104738627A (zh) | 维生素亚麻籽油复方软胶囊及其制备方法 | |
| CN110236197A (zh) | 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 | |
| CN109965271A (zh) | 一种小儿脑发育专用型临床营养配方及其制备方法 | |
| CN103989179A (zh) | 含有银杏叶提取物的深海鱼油软胶囊 | |
| CN108113000A (zh) | 一种微藻营养褐藻凝胶的制备方法 | |
| CN1850065A (zh) | 口服共轭亚油酸及其衍生物用于增肌健体与皮肤美容的用途 | |
| CN109527579A (zh) | 一种奇亚籽油制品及其制备方法和该奇亚籽油制品的应用 | |
| CN106929229A (zh) | 一种羊尾脂香皂及其制作方法 | |
| CN103989180B (zh) | 含有丹参提取物的深海鱼油软胶囊 | |
| CN101732353A (zh) | 哈蟆油软胶囊及其制备方法 | |
| CN104958345A (zh) | 一种具有降血脂功能的大豆卵磷脂软胶囊及其制备方法 | |
| CN109259235A (zh) | 一种改善视力、促进大脑发育鳕鱼肝油软胶囊 | |
| CN109393057A (zh) | 一种降血脂配方食用植物油 | |
| CN1135294A (zh) | 一种记忆果及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190917 |